Cite
HARVARD Citation
Kivitz, A. et al. (n.d.). FRI0150 GS-9876, A NOVEL, HIGHLY SELECTIVE, SYK INHIBITOR IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: SAFETY, TOLERABILITY AND EFFICACY RESULTS OF A PHASE 2 STUDY. Annals of the rheumatic diseases. pp. 746-747. [Online].